Search

Author/Creator Atkinson, Nathan

2. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

Authors:
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Germline variant testing in serrated polyposis syndrome. Issue 5 (18th February 2022)

Authors:
Murphy, Aisling; Solomons, Joyce; Risby, Peter; Gabriel, Jessica; Bedenham, Tina; Johnson, Michael; Atkinson, Nathan; Bailey, Adam A; Bird‐Lieberman, Elizabeth; Leedham, Simon J; East, James E; Biswas, Sujata
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 37:Issue 5(2022)
Page Start:
861
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗